Authors:
STARK H
HULS A
LIGNEAU X
PURAND K
PERTZ H
ARRANG JM
SCHWARTZ JC
SCHUNACK W
Citation: H. Stark et al., DEVELOPMENT OF FUB-181, A SELECTIVE HISTAMINE H-3-RECEPTOR ANTAGONISTOF HIGH ORAL IN-VIVO POTENCY WITH 4-(OMEGA-(ARYLALKYLOXY)ALKYL)-1H-IMIDAZOLE STRUCTURE, Archiv der pharmazie, 331(6), 1998, pp. 211-218
Citation: S. Elz et al., METHYLHISTAPRODIFEN AND CONGENERS - HIGHLY POTENT AND SELECTIVE HISTAMINE H-1 RECEPTOR AGONISTS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 113-113
Authors:
STARK H
ELZ S
PERTZ H
LIGNEAU X
ARRANG JM
SCHWARTZ JC
SCHUNACK W
Citation: H. Stark et al., CIPROXIFAN, A SELECTIVE ANTAGONIST OF HIGH IN-VITRO AND IN-VIVO POTENCY AT HISTAMINE H-3-RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 99-99
Citation: R. Heim et al., CONGENERS OF 3-(2-BENZYLAMINOETHYL)-2,4-QUINAZOLINEDIONE - PARTIAL AGONISTS FOR RAT VASCULAR 5-HT2A RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 810-810
Citation: S. Elz et al., METHYLHISTAPRODIFEN AND CONGENERS - HIGHLY POTENT AND SELECTIVE HISTAMINE H-1 RECEPTOR AGONISTS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 924-924
Citation: R. Heim et al., DERIVATIVES OF 3-(2-AMINOETHYL)-2,4-QUINAZOLINEDIONE - PARTIAL AGONISM ON VASCULAR 5-HT2A RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 106-106
Citation: S. Elz et al., STEREOSELECTIVITY AND EFFECTS OF NOVEL 5-HT4 RECEPTOR ANTAGONISTS ANDPARTIAL AGONISTS - COMPARISON OF RAT ESOPHAGUS AND GUINEA-PIG ILEUM, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 95-95
Authors:
MAZUMDER A
NEAMATI N
SUNDER S
SCHULZ J
PERTZ H
EICH E
POMMIER Y
Citation: A. Mazumder et al., CURCUMIN ANALOGS WITH ALTERED POTENCIES AGAINST HIV-1 INTEGRASE AS PROBES FOR BIOCHEMICAL-MECHANISMS OF DRUG-ACTION, Journal of medicinal chemistry, 40(19), 1997, pp. 3057-3063
Citation: H. Pertz, NATURALLY-OCCURRING CLAVINES - ANTAGONISM PARTIAL AGONISM AT 5-HT2A RECEPTORS AND ANTAGONISM AT ALPHA(1)-ADRENOCEPTORS IN BLOOD-VESSELS, Planta medica, 62(5), 1996, pp. 387-392
Authors:
EICH E
PERTZ H
KALOGA M
SCHULZ J
FESEN MR
MAZUMDER A
POMMIER Y
Citation: E. Eich et al., (-)-ARCTIGENIN AS A LEAD STRUCTURE FOR INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE, Journal of medicinal chemistry, 39(1), 1996, pp. 86-95
Authors:
SCHLICKER E
PERTZ H
BITSCHNAU H
PURAND K
KATHMANN M
ELZ S
SCHUNACK W
Citation: E. Schlicker et al., EFFECTS OF IODOPROXYFAN, A POTENT AND SELECTIVE HISTAMINE H-3 RECEPTOR ANTAGONIST, ON ALPHA(2) AND 5-HT3 RECEPTORS, Inflammation research, 44(7), 1995, pp. 296-300
Citation: H. Pertz et S. Elz, IN-VITRO PHARMACOLOGY OF SARPOGRELATE AND THE ENANTIOMERS OF ITS MAJOR METABOLITE - 5-HT2A RECEPTOR SPECIFICITY, STEREOSELECTIVITY AND MODULATION OF RITANSERIN-INDUCED DEPRESSION OF 5-HT CONTRACTIONS IN RAT TAIL ARTERY, Journal of Pharmacy and Pharmacology, 47(4), 1995, pp. 310-316
Citation: H. Pertz, 5-HYDROXYTRYPTAMINE (5-HT) CONTRACTS THE GUINEA-PIG ISOLATED ILIAC ARTERY VIA 5-HT(1)-LIKE AND 5-HT(2) RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 348(6), 1993, pp. 558-565